Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q79365348)
Watch
English
Neuroprotection in Parkinson's disease: and now for something completely different?
scientific article published on 01 December 2006
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
title
Neuroprotection in Parkinson's disease: and now for something completely different?
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
main subject
Parkinson's disease
1 reference
based on heuristic
inferred from title
author
Anthony Lang
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
publication date
1 December 2006
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
published in
Lancet Neurology
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
volume
5
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
issue
12
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
page(s)
990-991
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
cites work
TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of deprenyl on the progression of disability in early Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of deprenyl and levodopa on the progression of Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selegiline slows the progression of the symptoms of Parkinson disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled, randomized, delayed-start study of rasagiline in early Parkinson disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Levodopa and the progression of Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Timing of treatment initiation in Parkinson's disease: a need for reappraisal?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neuroprotective agents for clinical trials in Parkinson's disease: a systematic assessment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Issues in neuroprotection clinical trials in Parkinson's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970605-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1474-4422(06)70605-6
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
PubMed ID
17110271
1 reference
stated in
Europe PubMed Central
PubMed ID
17110271
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17110271%20AND%20SRC:MED&resulttype=core&format=json
retrieved
22 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
